2020
DOI: 10.1016/j.oraloncology.2020.104723
|View full text |Cite
|
Sign up to set email alerts
|

Targeting tumor-associated macrophages in head and neck squamous cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
39
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(39 citation statements)
references
References 111 publications
0
39
0
Order By: Relevance
“…PD-L1 can inhibit T-cell activation and contribute to tumour immune evasion in many cancers, like liver cancer and mammary cancer, and macrophages that in ltrate into liver cancers can express higher levels of PD-L1; therefore, we assumed that the same trend would occur in OSCC. [32][33][34] In this study, we found that the macrophages that in ltrated into ER-stressed OSCC tissues expressed high levels of PD-L1 and that the PD-L1 levels were negatively correlated with overall survival. Macrophages are classi ed into M1 and M2 macrophages, where M1 macrophages play a protective role and M2 macrophages promote tumour growth.…”
Section: Discussionmentioning
confidence: 52%
“…PD-L1 can inhibit T-cell activation and contribute to tumour immune evasion in many cancers, like liver cancer and mammary cancer, and macrophages that in ltrate into liver cancers can express higher levels of PD-L1; therefore, we assumed that the same trend would occur in OSCC. [32][33][34] In this study, we found that the macrophages that in ltrated into ER-stressed OSCC tissues expressed high levels of PD-L1 and that the PD-L1 levels were negatively correlated with overall survival. Macrophages are classi ed into M1 and M2 macrophages, where M1 macrophages play a protective role and M2 macrophages promote tumour growth.…”
Section: Discussionmentioning
confidence: 52%
“…Most DEGs were enriched in pathways related to immunity and inflammation, which indicates that the malignant transformation of oral cancer may be closely related to dysfunction of the immune system and inflammation. Similarly, Cheng et al 29 found that tumor‐associated macrophages (TAMs) are associated with poorer prognosis in HNSCC, and TAMs could promote cancer progression and inhibit the immune response through adaptive and innate immune mechanisms. Chan et al 30 discovered that OSCC was usually accompanied by inflammation and high levels of oxidative stress.…”
Section: Discussionmentioning
confidence: 97%
“…et al29 found that tumor-associated macrophages (TAMs) are associated with poorer prognosis in HNSCC, and TAMs could promote cancer progression and inhibit the immune response through adaptive and innate immune mechanisms. Chan et al 30 discovered that OSCC was usually accompanied by inflammation and high levels of oxidative stress.…”
mentioning
confidence: 99%
“…By depleting the immunosuppressive function or evoking anti-tumor ability, therapeutic strategies targeting TAMs show promising preclinical and clinical effects. Now, macrophage-centered therapeutic approaches such as anti-PD-1 T-cell, targeted therapeutics that can reactivate antitumor T-cell responses, are entering the clinical arena [154,157].…”
Section: Hsv-1 (Herpes Simplex Virus Type 1)mentioning
confidence: 99%